• Physicians and other providers may be hesitant to query symptoms of psychosis.
• Retained insight can make PDP symptoms seem mild and nontroublesome.
• Cognitive impairment may impede evaluation of psychosis symptoms. 6 For all of these reasons, PDP is probably under-recognized. 7 Overall, this delay in recognizing PDP can lead to symptoms becoming severe before a diagnosis of PDP is made.
7,10,11

Risk Factors and Emergence of Parkinson's Disease Psychosis
The risk for developing PDP can be influenced by both endogenous and exogenous factors. Endogenous risk factors implicated in PDP include advanced age, severity of PD, duration of PD, depression, cognitive impairment, and sleep disturbances. 7, 8, 12, 13 Exogenous factors may trigger PDP to emerge, or may worsen mild or subclinical PDP. These can include systemic disorders, including urinary tract (or other) infections, dehydration, fever, and medications. Both dopaminergic and anticholinergic medications increase the risk for PDP. Indeed, medications used to treat the motor systems of PD may also trigger and/or increase PDP symptoms, including levodopa: 8 as PD advances levodopa dosage tends to increase, with an increased risk for PDP. Other medications commonly used to treat PD motor systems may also increase PDP, especially dopamine agonists, selegiline, amantadine, and anticholinergics. 13 PDP is often thought of as a side effect of dopaminergic therapy.
14 Increasing evidence, however, suggests that PDP is a manifestation of the underlying neurodegeneration of PD and is related to progression of the underlying disease. 12, 14 Dosage and duration of dopamine replacement therapy have not been consistently correlated with PDP. 12, 15, 16 In an evaluation of 422 patients with PD and hallucinations, drug treatment was not identified as a risk factor for emergence of hallucinations in PD. 15 In addition, in a community-based study of 245 patients with PD, anti-parkinsonian drug therapy was not shown to be associated with psychosis. 4 In a study evaluating intravenous levodopa in patients with PDP, visual hallucinations did not appear to correlate with higher plasma levodopa nor to sudden changes in plasma levodopa levels. 17 A proposed pathophysiologic diagram of hallucinations in PD is provided (see Figure 1 ).
Symptoms
Visual hallucinations are the most common symptoms of PDP. 7, 14, 18, 19 Cognitive impairment and/or dementia are independent risk factors for hallucinations, and the prevalence of hallucinations is higher in PD patients with dementia than in PD patients without dementia. 5, 6, 20 PDP tends to develop in parallel with dementia, but can also herald cognitive impairment. 7, 8 Visual hallucinations are often preceded by sleep disturbances, vivid dreams, or REM sleep behavior disorder. 21 While most hallucinations in PDP are visual, as PDP progresses, auditory, tactile, gustatory, and olfactory hallucinations can also occur. 9, 11 Hallucinations can occur at any time of day but are more frequent in the evening and at night. 18 Older patients may be more likely to have nonvisual or mixed hallucinations than hallucinations that are purely visual in nature. 22 Visual hallucinations include passage hallucinations (brief visions of a person, or more commonly an animal, passing sideways) and presence hallucinations (sensation of somebody's presence when, in fact, no person is there). 7, 9, 14 More complex visual hallucinations can occur, consisting of one or more people, who may or may not be familiar, and may be living, or deceased. Also, visual hallucinations can be of animals, children, or objects. 6 Illusions are misinterpretations of a real external, essentially visual stimulus, for example, seeing a tree as a person or patterns on carpets as if they are moving. 7, 9, 14 PDP involves a spectrum of symptoms that extends beyond formed visual hallucinations and illusions. The content of delusions is commonly paranoid, often centered on beliefs of infidelity and abandonment. 11, 14, 20 Delusions in patients with PDP may involve family members, which can add to the stress experienced by the family. 11 Frégoli syndrome 23 (a rare disorder in which a person holds a belief that different people are in fact a single person who changes their appearance or is in disguise), and
Capgras syndrome 24 (a delusion that someone has been replaced by an Fénelon, 2008. 6 identical-looking impostor) have also been reported in the course of PDP, particularly in PD patients with dementia. PDP is typically progressive over time, both in frequency and severity. Early symptoms of PDP have sometimes been considered as 'benign' since insight is often retained. However, in many patients who initially have insight into their hallucinations, insight is lost as the disease progresses. 10 The likelihood that mild hallucinations will not increase in severity and/or frequency is low, frequently increasing within 2-3 years. 10 Nonvisual hallucinations also occur and can complicate management. 25 Even "benign," relatively minor psychotic symptoms can negatively impact quality of life 26 and PD patients with hallucinations have been associated with depression and anxiety, even when insight is retained. 7 As PDP progresses, delusions and paranoia can emerge, and these symptoms may become more troublesome, when accompanied by agitation.
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Recognition and Evaluation
Consensus diagnostic criteria for PDP have been outlined by the National
Institute of Neurological Disorders and Stroke (NINDS) and the National
Institutes of Mental Health (NIMH) Work Group (see Table 2 ). it is important to define symptom onset, duration (recurrent or continuous for 1 month), insight, cognition, medications being taken, and to exclude other systemic causes. Initially, symptoms tend to occur intermittently with varying frequency, and can increase from several times a month to multiple times a day. PDP symptoms will often recur and/or worsen over time. The persistence and progression of symptoms thus require regular monitoring. 14, 18 This evaluation typically occurs in the outpatient setting, but depending on the severity of psychosis, emergency care may be necessary.
Caregiver Burden
Caring for a person with PD is largely carried out by informal caregivers, such as spouses. Psychosis symptoms in PD are a strong predictor of increased caregiver burden. 30 As PDP progresses, the impact on the caregiver's social activities, emotional and physical health, and overall level of stress increases. 31 PDP progression and caregiver burden are both independent risk factors as well as leading causes for long-term care placement. 32, 33 Patients placed in a nursing home because of their PDP symptoms are likely to remain there permanently and have a higher mortality rate. 32, 34 A cross-sectional, population-based study in Norway was carried out in 94 caregivers of patients with PD who were living at home. 35 This study identified mental symptoms as the most consistent and powerful predictors of caregiver distress, which suggests that identification and treatment of mental symptoms may reduce the distress experienced by caregivers. In a 4-year, prospective, population-based study of 178 community-dwelling individuals with PD, also conducted in Norway, the presence of hallucinations emerged as the strongest predictor of institutionalization.
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Summary and Management Challenges
PDP is a frequent but under-recognized nonmotor complication in PD, with more than 50 % of patients with PD expected to develop psychosis at some time. 8 This contributes significantly to diminished quality and activities of patient and caregiver daily life, and an increased risk for morbidity, and long-term care placement. Further, the presence of psychotic symptoms has been shown to be an independent predictor of mortality in PD. 36 A better understanding of what causes PDP is emerging, and suggests that the effects of the underlying disease on dopaminergic, serotoninergic, and/or cholinergic pathways may be a major contributor to PDP, which can be triggered by dopaminergic medications and other 
